Estrogen receptors in giant cell arteritis. An immunocytochemical, Western blot and RT-PCR study

Clinical and Experimental Rheumatology

Volumn 17, Issue 6, 1999, Pages 671-677

  Petursdottir, V ^a   Nordborg, E ^a   Moraghebi, N ^a   Persson, M ^a   Nordborg, C ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Estrogen receptors; Giant cell arteritis; Inflammation; Vascular smooth muscle cells

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; FEMALE; GIANT CELL ARTERITIS; HUMAN; IMMUNOCYTOCHEMISTRY; INFLAMMATION; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TEMPORAL ARTERY; VASCULAR SMOOTH MUSCLE; VASCULITIS; WESTERN BLOTTING;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TEMPORAL ARTERIES; TEMPORAL ARTERITIS; TUNICA MEDIA;

EID: 0032726624     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. BIGNON JD, BARRIER J, SOULILLOU JP, MARTIN P, GROLLEAU JY: HLA DR4 and giant cell arteritis. Tissue Antigens 1984; 24: 60-2.
2. BENGTSSON BA: Epidemiology of giant cell arteritis. Baillières Clin Rheumatol 1991; 5: 379-85.
3. NORDBORG E, BENGTSSON BA, NORDBORG C: Temporal artery morphology and morphometry in giant cell arteritis. APMIS 1991; 99: 1013-23.
4. ANDERSSON R, JONSSON R, TARKOWSKI A, BENGTSSON BA, MALMVALL BE: T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis. Ann Rheum Dis 1987; 46: 915-23.
5. SCHAUFELBERGER C, STEMME S, ANDERSSON R, HANSSON GK: T lymphocytes in giant cell arteritic lesions are polyclonal cells expressing alpha beta type antigen receptors and VLA-1 integrin receptors. Clin Exp Immunol 1993; 91: 421-8.
6. WEYAND CM, SCHONBERGER J, OPPITZ U, HUNDER NN, HICOK KC, GORONZY JJ: Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med 1994; 179: 951-60.
7. RUSSO MG, WAXMAN J, ABDOH AA, SEREBRO LH: Correlation between infection and the onset of the giant cell (temporal) arteritis syndrome. A trigger mechanism? Arthritis Rheum 1995; 38: 374-80.
8. KARAS RH, PATTERSON BL, MENDELSOHN ME: Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994; 89: 1943-50.
9. CUTOLO M, SULLI A, SERIOLO B, ACCARDO S, MASI AT: Estrogens, the immune response and autoimmunity. Clin Exp Rheumatol 1995; 13: 217-26.
10. FOX HS: Sex steroids and the immune system. Ciba Found Symp 1995; 191: 203-11.
11. SCHUURS AH, VERHEUL HA: Effects of gender and sex steroids on the immune response. J Steroid Biochem 1990; 35: 157-72.
12. GREENE GL, GILNA P, WATERFIELD M, BAKER A, HORTY, SHINE J: Sequence and expression of human estrogen receptor complementary DNA. Science 1986; 231: 1150-4.
13. KANNEL WB, HJORTLAND MC, McNAMARA PM, GORDON T: Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976; 85: 447-52.
14. MESSERLI FH, GARAVAGUA GE, SCHMIEDER RE, SUNDGAARD RIISE K, NUNEZ BD, AMODEO C: Disparate cardiovascular findings in men and women with essential hypertension. Ann Intern Med 1987; 107: 158-61.
15. KNOPP RH: Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime. Am J Obstet Gynecol 1988; 2: 1630-43.
16. TIKKANEN MJ, NIKKILA EA, KUUSI T, SIPINEN S: Effects of oestradiol and levonorgestrel on lipoprotein lipids and postheparin plasma lipase activities in normolipoproteinaemic women. Acta Endocrinol (Copenh) 1982; 99: 630-5.
17. LOSORDO DW, KEARNEY M, KIM EA, JEKANOWSKI J, ISNER JM: Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994; 89: 1501-1510.
18. CHENG LP, KUWAHARA M, JACOBSSON J, FOEGH ML: Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts. Transplantation 1991; 52: 967-72.
19. FOEGH ML, ASOTRA S, HOWELL MH, RAMWELL PW: Estradiol inhibition of arterial neointimalhyperplasia after balloon injury. J Vase Surg 1994; 19: 722-6.
20. KEYES LE, MOORE LG, WALCHAK SJ, DEMPSEY EC: Pregnancy-stimulated growth of vascular smooth muscle cells: importance of protein kinase C-dependent synergy between estrogen and platelet-derived growth factor. J Cell Physiol 1996; 166: 22-32.
21. PETURSDOTTIR V, NORDBORG E, NORDBORG C: Atrophy of the aortic media in giant cell arteritis. APMIS 1996; 104: 191-8.
22. KIRKWOOD TBL: The origins of human ageing. Philos Trans R Soc Lond B Biol Sci 1997; 352: 1765-72.
23. DUHAUT P, PINÈDE L, DEMOLOMBE-RAGUÉ S et al.: Giant cell arteritis and polymyalgia rheumatica: Are pregnancies a protective factor? A prospective, multicentre case-control study. Rheumatology 1999; 38:118-23.
24. GROSSMAN CJ: Regulation of the immune system by sex steroids. Endocr Rev 1984; 5: 435-55.
25. PAAVONEN T, ANDERSSON LC, ADLERCREUTZ H: Sex hormone regulation of in vitro immune response. Estradiol enhances human B cell maturation via inhibition of suppressor T cells in pokeweed mitogen-stimulated cultures. J Exp Med 1981;154:1935-45.
26. MAOZ H, KAISER N, HALIMI M et al:: The effect of estradiol on human myelomonocytic cells. 1. Enhancement of colony formation. J Reprod Immunol 1985;7:325-35.
27. VERNON ROBERTS B: The effects of steroid hormones on macrophage activity. Int Rev Cytol 1969; 25: 131-59.
28. FRAZIER JESSEN MR, KOVACS EJ: Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J Immunol 1995; 154: 1838-45.
29. CUTOLO M, ACCARDO S, VILLAGGIO B et al.: Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. J Clin Endocrinol Metab 1996; 81: 820-7.
30. GULSHAN S, McCRUDEN AB, STIMSON WH: Oestrogen receptors in macrophages. Scand J Immunol 1990; 31: 691-7.
31. WADA K, ITOH T, NAKAGAWA M, MISAO R, MORI H, TAMAYA T: Estrogen binding sites in peripheral blood monocytes and effects of danazol on their sites in vitro. Gen Pharmacol 1992; 23: 693-700.
32. BAYARD F, CLAMENS S, MEGGETTO F, BLAES N, DELSOL G, FAYE JC: Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology 1995; 136: 1523-9.
33. ORIMO A, INOUE S, IKEGAMI A et al.: Vascular smooth muscle cells as target for estrogen. Biochem Biophys Res Commun 1993; 195: 730-6.
34. BAULIEU EE, ROBELP: Non-genomic mechanisms of action of steroid hormones. Ciba Found Symp 1995; 191: 24-37.
35. INOUES, HOSHINO S, MIYOSHI H et al.: Identification of a novel isoform of estrogen receptor, a potential inhibitor of estrogen action, in vascular smooth muscle cells. Biochem Biophys Res Commun 1996; 219: 766-72.
36. KARAS RH, BAUR WE, VAN EICKLES M, MENDELSOHN ME: Human vascular smooth muscle cells express an estrogen receptor isoform. FEBS Lett 1995; 377: 103-8.
37. OURSLER MJ, OSDOBY P, PYFFEROEN J, RIGGS BL, SPELSBERG TC: Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 1991; 88: 6613-7.
38. PENSLER JM, RADOSEVlCH JA, HIGBEE R, LANGMAN CB: Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors. J Bone Miner Res 1990; 5: 797-802.
39. WHITAKER SB, BOUQUOT JE: Estrogen and progesterone receptor status of central giant cell lesions of the jaws. Oral Surg Oral Med Oral Pathol 1994; 77: 641-4.